NGE Intellectual Property attorneys Kevin O'Connor and Tom Campbell will attend the American Conference Institute's (ACI) 7th Annual Summit on Life Sciences IP Due Diligence Conference, which will take place from December 4 -5, 2024, in Boston, MA. This event will provide attendees with the tools and information needed to create strategies and provide robust, valuable and protected IP assets that can stand the test of time.

On December 4, Kevin will participate in the panel discussion "Ensuring Freedom-to-Operate in the Current IP Landscape: Defusing Landmines and Avoiding Pitfalls to Get the "All-Clear" for the Deal." The session will examine how new case law and legal and regulatory developments influence Freedom to Operate (FTO) reviews in the life sciences and explore various approaches to FTO analysis based on these developments. The panel will also discuss how to uncover solutions to potential infringement areas and assess the scope of FTO's potential FTO impediments to products and technologies with or without patent protection.

Click here to learn more about this event.